Volume 89 Issue 51 | p. 23 | Concentrates
Issue Date: December 19, 2011

Selcia Doubles Its Radiolabeling Labs

Department: Business
Keywords: API, radiolabeling, carbon 14

Selcia has doubled its capacity to conduct carbon-14 radiolabeling projects in Ongar, Essex, England. The company says it has been preparing radiolabeled active pharmaceutical ingredients for customers with compounds in Phase I clinical trials since September 2010, after certification by British authorities. Drug companies create radiolabeled versions of developmental compounds for metabolism, mass-balance, and microtracer studies, Selcia notes.

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society